The future of the HIV epidemic in South Africa

HIV/AIDS in South Africa Second Edition

Volumn , Issue , 2010, Pages 585-590

  Karim, Salim S Abdool ^a   Karim, Quarraisha Abdool ^a  

^a Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927073106     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9781139062404.036     Document Type: Chapter

References (5)

1. Abdool Karim SS, Abdool Karim Q, Baxter C. ‘Antiretroviral therapy: Challenges and options for South Africa.’ Lancet 2003; 362: 1499.
2. Abdool Karim SS, Abdool Karim Q. ‘Breaking the silence, one year later: Reflections on the Durban conference.’ AIDS Clinical Care 2001; 70: 63–65.
3. Celentano DD. ‘Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users.’ AIDS 2001; 15: 2311–2316.
4. Kasper T, Coetzee D, Louis F, Boulle A, Hilderbrand K. ‘Demystifying antiretroviral therapy in resource-poor settings.’ Essential Drugs Monitoring 2003; 32: 20–21.
5. Ostrow DE, Fox KJ, Chmiel JS, Silvestre A, Visscher BR, Vanable PA, et al. ‘Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men.’ AIDS 2002; 16: 775–780.